# Zhejiang Jingwei Pharmaceutical Co., Ltd. – FDA Inspection, Mar 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-jingwei-pharmaceutical-co-ltd/d77438d5-afeb-412d-9c55-24d797529e53
Source feed: FDA_Inspections

> FDA inspection 1086689 of Zhejiang Jingwei Pharmaceutical Co., Ltd., March 15, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086689
- Company Name: Zhejiang Jingwei Pharmaceutical Co., Ltd.
- Inspection Date: 2019-03-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1255518 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/zhejiang-jingwei-pharmaceutical-co-ltd/e5ee5165-7fcd-4824-ab1a-96c50c173ed1)
- [FDA Inspection 1010783 - 2017-03-02](https://www.keypedia.com/records/fda_inspections/zhejiang-jingwei-pharmaceutical-co-ltd/0f33300e-9fc8-4879-a89f-c741cc02b21c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)

Company: https://www.keypedia.com/companies/zhejiang-jingwei-pharmaceutical-co-ltd/f8f377b7-d943-41e1-b510-f712bcfd68ed

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c